BICX · BioCorRx Inc.
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had cash of $21,237 and working capital deficit of $8,231,326. During the six months ended June 30, 2026, the Company used net cash in operating activities of $873,260. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company's ability to continue as a going concern for the next twelve-month period since the date of the financial statements were issued.”View the 10-Q filed Aug 14, 2026
2 customers — 100% of revenue (three months ended June 30, 2026)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2026 included 100% from two customers of the Company's total revenues.”
2 customers — 99% of revenue (three months ended June 30, 2025)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2025 included 99% from two customers of the Company's total revenues.”
BioCorRx Inc. Earnings Call Transcripts
Quarterly earnings calls for BioCorRx Inc. (BICX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.